Cargando…
In Vivo Remodeling of Altered Autophagy-Lysosomal Pathway by a Phosphopeptide in Lupus
The phosphopeptide P140/Lupuzor, which improves the course of lupus disease in mice and patients, targets chaperone-mediated autophagy (CMA), a selective form of autophagy that is abnormally upregulated in lupus-prone MRL/lpr mice. Administered intravenously to diseased mice, P140 reduces the expres...
Autores principales: | Wang, Fengjuan, Tasset, Inmaculada, Cuervo, Ana Maria, Muller, Sylviane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589999/ https://www.ncbi.nlm.nih.gov/pubmed/33092174 http://dx.doi.org/10.3390/cells9102328 |
Ejemplares similares
-
Modulation of deregulated chaperone-mediated autophagy by a phosphopeptide
por: Macri, Christophe, et al.
Publicado: (2015) -
The Mitochondrion-lysosome Axis in Adaptive and Innate Immunity: Effect of Lupus Regulator Peptide P140 on Mitochondria Autophagy and NETosis
por: Bendorius, Mykolas, et al.
Publicado: (2018) -
Autophagy-Lysosomal Pathway as Potential Therapeutic Target in Parkinson’s Disease
por: Bonam, Srinivasa Reddy, et al.
Publicado: (2021) -
Lysosomes as a therapeutic target
por: Bonam, Srinivasa Reddy, et al.
Publicado: (2019) -
The Spliceosomal Phosphopeptide P140 Controls the Lupus Disease by Interacting with the HSC70 Protein and via a Mechanism Mediated by γδ T Cells
por: Page, Nicolas, et al.
Publicado: (2009)